Merit Medical Systems (NASDAQ:MMSI) Given New $107.00 Price Target at Barrington Research

Merit Medical Systems (NASDAQ:MMSI) had its target price lowered by Barrington Research from $109.00 to $107.00 in a research report sent to investors on Monday morning,Benzinga reports. Barrington Research currently has an outperform rating on the medical instruments supplier’s stock.

MMSI has been the topic of a number of other research reports. Wall Street Zen lowered Merit Medical Systems from a “strong-buy” rating to a “buy” rating in a research report on Sunday, April 5th. Needham & Company LLC reiterated a “buy” rating and set a $101.00 target price on shares of Merit Medical Systems in a research report on Wednesday, April 1st. Citigroup reiterated an “outperform” rating on shares of Merit Medical Systems in a research report on Monday. Weiss Ratings reiterated a “hold (c)” rating on shares of Merit Medical Systems in a research report on Friday, March 27th. Finally, BTIG Research initiated coverage on Merit Medical Systems in a research report on Friday, February 6th. They set a “buy” rating and a $107.00 target price on the stock. Eight research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. Based on data from MarketBeat, Merit Medical Systems has an average rating of “Moderate Buy” and an average target price of $99.56.

Merit Medical Systems Trading Down 1.6%

Shares of NASDAQ:MMSI opened at $69.79 on Monday. Merit Medical Systems has a 1 year low of $66.34 and a 1 year high of $100.19. The firm has a market capitalization of $4.16 billion, a price-to-earnings ratio of 32.92, a price-to-earnings-growth ratio of 2.05 and a beta of 0.64. The company has a debt-to-equity ratio of 0.46, a current ratio of 4.34 and a quick ratio of 2.95. The business’s 50 day moving average price is $72.88 and its 200-day moving average price is $80.58.

Merit Medical Systems (NASDAQ:MMSI) last announced its earnings results on Tuesday, February 24th. The medical instruments supplier reported $1.04 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.96 by $0.08. Merit Medical Systems had a return on equity of 13.82% and a net margin of 8.48%.The firm had revenue of $393.94 million for the quarter, compared to analyst estimates of $390.77 million. During the same quarter last year, the firm posted $0.93 EPS. The business’s revenue was up 10.9% on a year-over-year basis. Merit Medical Systems has set its FY 2026 guidance at 4.010-4.150 EPS. On average, equities research analysts forecast that Merit Medical Systems will post 3.63 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Brookstone Capital Management lifted its holdings in Merit Medical Systems by 22.8% in the 1st quarter. Brookstone Capital Management now owns 9,096 shares of the medical instruments supplier’s stock valued at $627,000 after purchasing an additional 1,688 shares in the last quarter. Mountain Pacific Investment Advisers LLC lifted its holdings in Merit Medical Systems by 8.8% in the 1st quarter. Mountain Pacific Investment Advisers LLC now owns 14,981 shares of the medical instruments supplier’s stock valued at $1,033,000 after purchasing an additional 1,207 shares in the last quarter. Diversified Trust Co lifted its holdings in Merit Medical Systems by 9.5% in the 1st quarter. Diversified Trust Co now owns 24,733 shares of the medical instruments supplier’s stock valued at $1,705,000 after purchasing an additional 2,146 shares in the last quarter. Corient Private Wealth LLC lifted its holdings in Merit Medical Systems by 99.4% in the 4th quarter. Corient Private Wealth LLC now owns 6,312 shares of the medical instruments supplier’s stock valued at $557,000 after purchasing an additional 3,146 shares in the last quarter. Finally, Alberta Investment Management Corp purchased a new position in Merit Medical Systems in the 4th quarter valued at $1,428,000. Hedge funds and other institutional investors own 99.66% of the company’s stock.

Merit Medical Systems Company Profile

Merit Medical Systems, Inc is a global manufacturer and marketer of a broad range of medical devices used in diagnostic and interventional procedures. The company’s product portfolio encompasses vascular access, drainage, embolotherapy, and interventional oncology devices, as well as radiofrequency ablation systems and hemostasis solutions. These products serve physicians and hospitals in critical care settings and support minimally invasive treatment options across multiple specialties, including cardiology, radiology, oncology, neurology and endoscopy.

Founded in 1987 by Fred Lampropoulos, Merit Medical Systems has grown through both organic development and targeted acquisitions to expand its technology offerings and geographic reach.